Epidemiology Practice Questions

Q: Which of the following is a live attenuated vaccine?

Rabies. **Explanation:** The question asks to identify a **live attenuated vaccine** from the given options. However, there appears to be a discrepancy in the provided key: **Rabies is NOT a live attenuated vaccine; it is an inactivated (killed) vaccine.** In the context of standard medical curriculum and NEET-PG, the options Measles, Oral Polio, and Yellow Fever are all classic examples of live attenuated vaccines. **1. Understanding the Correct Concept (The Discrepancy):** * **Rabies Vaccine:** Modern rabies vaccines (like PCEV or HDCV) used in humans are **Inactivated/Killed** vaccines. Live rabies vaccines are only used in veterinary medicine (oral baits for wildlife) due to the high fatality rate of the disease. * **Live Attenuated Vaccines:** These contain modified pathogens that replicate within the host to induce an immune response without causing the disease. Examples include **Measles, Mumps, Rubella (MMR), OPV (Sabin), Yellow Fever (17D strain), and BCG.** **2. Analysis of Options:** * **A. Measles:** A live attenuated vaccine (Edmonston-Zagreb strain). * **B. Rabies:** An **Inactivated vaccine**. If this is marked "Correct" in your source, it is likely a typographical error or refers to veterinary use. * **C. Oral Polio (Sabin):** A live attenuated vaccine. (Note: Salk/IPV is killed). * **D. Yellow Fever:** A live attenuated vaccine (17D strain). **3. NEET-PG High-Yield Clinical Pearls:** * **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**ubella/Rotavirus, **G**errman Measles, **M**easles/Mumps, **L**ive Polio, **S**mallpox, **V**aricella, **T**yphoid oral). * **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** states (except HIV patients with CD4 >200 for certain vaccines). * **Yellow Fever:** Provides immunity for life; the certificate is valid after 10 days of vaccination.

Q: The WHO Rose Questionnaire is used for assessment of which condition?

Angina. ### Explanation **Correct Answer: B. Angina** The **WHO Rose Questionnaire** is a standardized tool developed by Geoffrey Rose in 1962, specifically designed for the **epidemiological assessment of angina pectoris** and myocardial infarction in population studies. It is considered the "gold standard" for field surveys because it allows for the identification of ischemic heart disease symptoms without the immediate need for clinical examination or ECG. It focuses on the location, character, and provocation of chest pain (e.g., pain occurring during exertion and relieved by rest). **Analysis of Incorrect Options:** * **A. Alcohol addiction:** This is typically screened using the **CAGE questionnaire** (Cut down, Annoyed, Guilty, Eye-opener) or the **AUDIT** (Alcohol Use Disorders Identification Test). * **C. Deep vein thrombosis (DVT):** The clinical probability of DVT is assessed using the **Wells’ Score/Criteria**, not a standardized symptom questionnaire like the Rose. * **D. Arrhythmia:** Arrhythmias are primarily diagnosed via **Electrocardiogram (ECG)** or Holter monitoring; there is no specific "Rose Questionnaire" for rhythmic disturbances. **High-Yield Clinical Pearls for NEET-PG:** * **Sensitivity vs. Specificity:** The Rose Questionnaire has high specificity (approx. 90-95%) for identifying angina but moderate sensitivity, meaning it is excellent for ruling in the condition in epidemiological surveys. * **Modified Rose Questionnaire:** Often used in modern studies to include symptoms of intermittent claudication (Peripheral Arterial Disease). * **Other Important Questionnaires:** * **Kuppuswamy Scale:** Socio-economic status (Urban). * **Modified BG Prasad Scale:** Socio-economic status (Rural/Urban - based on Per Capita Income). * **APGAR Score:** Newborn well-being. * **Ponderal Index:** Fetal growth restriction.

Q: What is the incidence of suicide?

8-10 per 100,000 population. **Explanation:** The correct answer is **C. 8-10 per 100,000 population.** In epidemiology, the **Suicide Rate** is a specific mortality rate defined as the number of suicides per year per **100,000 population**. Globally and in India, suicide is considered a significant public health issue, but it remains a relatively rare event in statistical terms compared to common morbidities. Standardizing the denominator to 100,000 allows for meaningful comparisons across different regions and time periods. While global averages fluctuate (often cited between 9–12 per 100,000), the range of 8–10 is the classically accepted figure in standard textbooks like Park’s Preventive and Social Medicine. **Analysis of Incorrect Options:** * **Option A (per 100):** This would imply a 10% mortality rate from suicide, which is epidemiologically impossible for a general population. * **Option B (per 10,000):** This overestimates the incidence by tenfold. Denominators of 1,000 or 10,000 are typically used for Case Fatality Rates or specific disease prevalences, not suicide. * **Option D (per 1,000,000):** This would underestimate the burden, making it appear much rarer than it actually is. **High-Yield Clinical Pearls for NEET-PG:** * **Demographics:** In India, the highest suicide rates are often seen in the **15–29 years** and **30–44 years** age groups. * **Gender Paradox:** Globally, **females** have higher rates of suicide *attempts*, but **males** have higher rates of *completed* suicide (due to the use of more lethal methods). * **Methods:** In India, **poisoning** (especially pesticides) and **hanging** are the most common methods. * **Risk Factors:** Mental health disorders (specifically Depression and Schizophrenia) and social factors like marital disharmony or financial debt are leading triggers.

Q: Which of the following sets is termed as the epidemiological triad?

Agent, host, and environment. ### Explanation The **Epidemiological Triad** is the traditional model of infectious disease causation. It posits that a disease is the result of a complex interaction between three essential components: 1. **Agent:** The factor whose presence (or relative absence) is essential for the occurrence of the disease (e.g., bacteria, viruses, physical trauma, or nutritional deficiencies). 2. **Host:** The living human or animal that affords subsistence or lodgment to an infectious agent. Factors include age, immunity, genetics, and behavior. 3. **Environment:** All external factors (physical, biological, and social) that affect the agent and the host, influencing the transmission of the disease. The "equilibrium" of these three factors maintains health; a change in any one of them can initiate the disease process. #### Analysis of Incorrect Options: * **Option A:** These are terms describing the **frequency and distribution** of disease in a population, not the factors causing it. * **Option C:** These are **measures of morbidity**. Incidence refers to new cases, while prevalence refers to all current cases (new + old). * **Option D:** While "Agent" is correct, "Man" is only one type of host, and "Disease" is the *outcome* of the triad's interaction, not a component of the triad itself. #### High-Yield Clinical Pearls for NEET-PG: * **Advanced Model:** For non-communicable diseases (NCDs), the **"Web of Causation"** (proposed by MacMahon and Pugh) is used instead of the triad. * **Epidemiological Wheel:** This model emphasizes the interaction between the host and the environment, with the host's genetic core at the center, often used for chronic diseases. * **Time:** Sometimes considered the "fourth dimension" of the triad, representing the incubation period or duration of the disease.

Q: The time difference between the screening test and the standard test is known as:

Lead time. ### Explanation **Lead Time** is defined as the period between the early detection of a disease (through screening) and the time when it would have been diagnosed naturally due to the onset of clinical symptoms. * **Why it is correct:** Screening aims to identify diseases in the "pre-symptomatic" phase. By detecting a condition earlier than a standard diagnostic test would, we gain "Lead Time." It is important to note that Lead Time does not necessarily improve the prognosis; it may simply increase the duration for which the patient is aware of their illness (**Lead Time Bias**). **Analysis of Incorrect Options:** * **Generation Time:** This is the interval between the receipt of infection by a host and the maximum infectivity of that host. It is an epidemiological concept used to measure the spread of infectious diseases, distinct from screening. * **CIP (Cold Intermediate Phase):** This is a distractor. In epidemiology, we more commonly discuss the **Incubation Period** (time from infection to symptoms) or the **Latent Period** (time from infection to becoming infectious). * **Lag Time:** In a medical context, this often refers to the delay between an exposure and the outcome, or the delay between a medical intervention and its observable effect. It is not a standard term for screening intervals. **High-Yield Clinical Pearls for NEET-PG:** * **Screening vs. Diagnostic Test:** Screening is done on apparently healthy populations (high sensitivity), while diagnostic tests are for those with symptoms (high specificity). * **Iceberg Phenomenon:** Screening aims to identify the "submerged" portion of the iceberg (undiagnosed cases). * **Length Bias:** Screening tends to disproportionately detect slowly progressing cases (which have a longer pre-symptomatic phase), making the screening program appear more effective than it is.

Q: Under the National Leprosy Elimination Programme, mass survey for leprosy is conducted if the prevalence of leprosy is more than:

10/1000. **Explanation:** Under the **National Leprosy Elimination Programme (NLEP)**, the strategy for case detection is primarily based on **Passive Surveillance**. However, **Active Surveillance** (Mass Surveys) is reserved for specific epidemiological conditions to ensure cost-effectiveness and resource optimization. **1. Why 10/1000 is Correct:** A mass survey (house-to-house search) is indicated only in areas where the prevalence of leprosy is **high**, defined as **≥ 1% or 10 per 1000 population**. In these hyper-endemic pockets, the risk of transmission is significant, and passive detection alone is insufficient to break the chain of infection. **2. Analysis of Incorrect Options:** * **1/1000 (Option A):** This represents the "Elimination Goal" for leprosy (less than 1 case per 10,000 population, though often confused with 1/1000 in older texts). At this low prevalence, routine surveillance and voluntary reporting are the standard protocols. * **5/1000 (Option B):** While this indicates a moderate burden, it does not meet the NLEP criteria for a full-scale mass survey. * **20/1000 (Option D):** This is well above the threshold. While a survey would certainly be conducted here, the *minimum* threshold defined by the programme is 10/1000. **High-Yield Clinical Pearls for NEET-PG:** * **Elimination Definition:** Prevalence < 1 case per 10,000 population. * **Leprosy Case Detection Campaign (LCDC):** A newer NLEP initiative focusing on high-endemic districts for active case finding. * **MDT Regimen (WHO):** * **PB (Paucibacillary):** Rifampicin + Dapsone for 6 months. * **MB (Multibacillary):** Rifampicin + Dapsone + Clofazimine for 12 months. * **Surveillance Types:** Passive surveillance is the mainstay of NLEP in low-endemic areas to avoid "over-diagnosis" and resource wastage.

Q: All the following indicators are used to measure disability rates in a community except?

Human poverty index. **Explanation:** The correct answer is **B. Human Poverty Index (HPI)**. In epidemiology, health indicators are categorized into various groups such as mortality, morbidity, and disability rates. **Why Human Poverty Index is the correct answer:** The Human Poverty Index is a **socio-economic indicator**, not a disability indicator. It measures deprivation in the same dimensions as the Human Development Index (longevity, knowledge, and a decent standard of living). It reflects the quality of life and economic status of a community rather than specific physical or mental functional limitations. **Analysis of incorrect options (Disability Indicators):** * **Sullivan’s Index (Disability-free life expectancy):** This is calculated by subtracting the duration of bed disability and inability to perform major activities from the life expectancy. It is considered one of the most advanced indicators of relevant health. * **Health-Adjusted Life Expectancy (HALE):** This measures the equivalent number of years in full health that a newborn can expect to live based on current mortality and health states. * **Disability-Adjusted Life Year (DALY):** A composite measure of the burden of disease. It expresses the years of life lost due to premature death (**YLL**) plus the years lived with disability (**YLD**) for specified health conditions. (1 DALY = 1 lost year of healthy life). **High-Yield NEET-PG Pearls:** * **Sullivan's Index** is the most commonly used indicator for "Disability-free life expectancy." * **DALY** is the best measure for "Global Burden of Disease." * **PQLI (Physical Quality of Life Index)** includes Infant Mortality, Life Expectancy at Age 1, and Literacy (Scale 0-100). * **HDI (Human Development Index)** includes Life Expectancy at birth, Mean/Expected years of schooling, and GNI per capita (Scale 0-1).

Q: Denominator while calculating the secondary attack rate includes?

All susceptible amongst close contacts. ### Explanation **Secondary Attack Rate (SAR)** is a measure of the spread of a communicable disease within a specific group (like a household or dormitory) following the introduction of an index case. It reflects the **infectivity** of an agent and the effectiveness of transmission. #### Why Option C is Correct The formula for Secondary Attack Rate is: $$\text{SAR} = \frac{\text{Number of exposed persons developing the disease within the incubation period}}{\text{Total number of susceptible close contacts}} \times 100$$ The denominator must only include **susceptible** individuals because those who are already immune (due to prior infection or vaccination) are not at risk of contracting the disease from the primary case. Including non-susceptible individuals would artificially lower the rate. #### Why Other Options are Incorrect * **Option A & D:** These are too broad. SAR focuses on "close contacts" (usually household members) where the intensity of exposure is high. Including an entire village or fifty houses shifts the metric toward a general "Attack Rate" rather than a "Secondary" one. * **Option B:** While "close contacts" is the right setting, it is incomplete. It fails to exclude those who are already immune. A person with lifelong immunity is a contact, but they cannot be part of the denominator for a new infection rate. #### High-Yield Pearls for NEET-PG * **Numerator:** Excludes the **Primary Case** (the first case to introduce the infection into the group). * **Denominator:** Excludes both the Primary Case and those already immune. * **Utility:** SAR is the best indicator of **communicableity/infectivity**. It is also used to evaluate the efficacy of prophylactic measures (e.g., vaccines) given to contacts. * **Timeframe:** Cases are only counted if they occur within the range of **one incubation period** after exposure to the primary case.

Q: Which of the following characteristics is NOT of much importance in a screening test?

High specificity. ### Explanation In epidemiology, a **screening test** is designed to identify asymptomatic individuals who may have a disease. The primary goal is to "cast a wide net" to ensure no potential cases are missed. **Why High Specificity is NOT of much importance:** Specificity refers to the ability of a test to correctly identify those *without* the disease (True Negatives). While desirable, high specificity is not the priority for a screening test. If a screening test has lower specificity, it results in more "False Positives." These individuals are subsequently filtered out during the **Diagnostic Test**, which must have high specificity to confirm the disease. Therefore, for screening, we prioritize capturing all possible cases over the accuracy of excluding healthy ones. **Analysis of Other Options:** * **High Sensitivity (C):** This is the **most important** characteristic. High sensitivity ensures a low "False Negative" rate, meaning the test rarely misses people who actually have the disease. * **Low Cost (A):** Screening is applied to large, healthy populations. For a program to be viable and cost-effective, the test must be inexpensive. * **High Safety Margin (B):** Since the test is performed on asymptomatic individuals, it must be non-invasive and safe (e.g., ultrasound or BP measurement) to ensure high public compliance and ethical standards. **NEET-PG High-Yield Pearls:** * **Screening Test:** High Sensitivity (to avoid False Negatives). * **Diagnostic Test:** High Specificity (to avoid False Positives/over-treatment). * **Lead Time:** The period between early detection by screening and the time of usual clinical diagnosis. * **Yield:** The amount of previously unrecognized disease diagnosed as a result of screening.

Question 1

Which of the following is a live attenuated vaccine?

Accepted Answer

Rabies

Answer

Measles

Answer

Oral polio

Answer

Yellow fever

Question 2

The WHO Rose Questionnaire is used for assessment of which condition?

Accepted Answer

Angina

Answer

Alcohol addiction

Answer

Deep vein thrombosis (DVT)

Answer

Arrhythmia

Question 3

Mc Keon, in the nineteenth century, studied the decline in the incidence of infectious diseases like tuberculosis. He explained the co-relation between this decline and attributed it to factors better understood in terms of which of the following?

Accepted Answer

Social and economic factors

Answer

Increased awareness and knowledge

Answer

Behavioral interventions

Answer

Medical interventions

Question 4

What is the incidence of suicide?

Accepted Answer

8-10 per 100,000 population

Answer

8-10 per 100 population

Answer

8-10 per 10,000 population

Answer

8-10 per 1,000,000 population

Question 5

Which of the following sets is termed as the epidemiological triad?

Accepted Answer

Agent, host, and environment

Answer

Endemic, epidemic, and outbreaks

Answer

Incidence, prevalence, and disease load

Answer

Agent, man, and disease

Question 6

The time difference between the screening test and the standard test is known as:

Accepted Answer

Lead time

Answer

Generation time

Answer

CIP

Answer

Lag time

Question 7

Under the National Leprosy Elimination Programme, mass survey for leprosy is conducted if the prevalence of leprosy is more than:

Accepted Answer

10/1000

Answer

1/1000

Answer

5/1000

Answer

20/1000

Question 8

All the following indicators are used to measure disability rates in a community except?

Accepted Answer

Human poverty index

Answer

Sullivan's index

Answer

Health-adjusted life expectancy

Answer

Disability-adjusted life year

Question 9

Denominator while calculating the secondary attack rate includes?

Accepted Answer

All susceptible amongst close contacts

Answer

All the people living in the next fifty houses

Answer

All the close contacts

Answer

All susceptible in the whole village

Question 10

Which of the following characteristics is NOT of much importance in a screening test?

Accepted Answer

High specificity

Answer

Low cost

Answer

High safety margin

Answer

High sensitivity

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?